Diagnosis and Treatment

Early diagnostic:

Following the provisions of the WHO for the elimination of leprosy this is one of the strategies that we must work with in order to reduce the reservoirs of bacilli present in patients without diagnosis and thus avoid the increase or the presence of some degree of disability .

Our program with our trained and trained staff annually seeks new cases in communities where patients have already been diagnosed; in order to be evaluating the cohabitants periodically.

Attention by General Medicine: The patient suffering from leprosy is treated and is provided free of charge the necessary drugs to treat another pathology different from his illness

PQT Treatment: The Entity offers multi and paucibacillary treatment free of charge according to the patient's need according to the New Leprosy Care Guide

Physical Rehabilitation: The program has a health professional who guarantees patients the development of promotion and prevention activities that favors the non-appearance of new disabilities.

Psychosocial Rehabilitation: the multidisciplinary team of the program possesses the human quality to take an active part in the collaboration, support and accompaniment of patients throughout their process of psychosocial management of the disease.

CURRENT TREATMENT

PAUCIBACILAR ADULTS TTO 6 MONTHS
SUPERVISED MONTHLY DOSE
RIFAMPICINA 600 MG.

DAILY DOSE SELF-ADMINISTERED
DAPSONA DDS 100 MG

MULTIBACILAR ADULTS TTO 24 MONTHS
SUPERVISED MONTHLY DOSE
RIFAMPICINA 600 MG
CLOFAXIMINA 300 MG

DAILY DOSE SELF-ADMINISTERED
CLOFAXIMINA 50 MG
DAPSONA DDS 100 MG

PAUCIBACILAR CHILDREN TTO 6 MONTHS
SUPERVISED MONTHLY DOSE
RIFAMPICINA 450 MG

DAILY DOSE SELF-ADMINISTERED
DAPSONA DDS 50 | MG

MULTIBACILAR CHILDREN TTO 12 MONTHS
SUPERVISED MONTHLY DOSE
RIFAMPICINA 450 MG
CLOFAXIMINA 150 MG

DAILY DOSE SELF-ADMINISTERED
CLOFAXIMINA 50 MG INTERDIARIOS
DAPSONA DDS 50 MG